Lars Viktrup

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi The risk of lower urinary tract symptoms five years after the first delivery
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Denmark
    Neurourol Urodyn 21:2-29. 2002
  2. pmc Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Lars Viktrup
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    BMC Urol 12:30. 2012
  3. pmc Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial
    Alex Tong Long Lin
    Division of Urology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
    BMC Urol 8:2. 2008
  4. ncbi [Urinary incontinence during 12 years after delivery]
    Lars Viktrup
    Københavns Universitet og Glostrup Hospital, Gynaekologisk og obstetrisk afdeling, Denmark
    Ugeskr Laeger 171:3073-7. 2009
  5. doi Incidence and remission of lower urinary tract symptoms during 12 years after the first delivery: a cohort study
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Copenhagen, Denmark
    J Urol 180:992-7. 2008
  6. ncbi Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy
    Lars Viktrup
    Duloxetine Urinary Incontinence Study Group, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Eur J Obstet Gynecol Reprod Biol 133:105-13. 2007
  7. ncbi A retrospective pooled analysis of duloxetine safety in 23,983 subjects
    James Gahimer
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    Curr Med Res Opin 23:175-84. 2007
  8. ncbi Risk of stress urinary incontinence twelve years after the first pregnancy and delivery
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Denmark
    Obstet Gynecol 108:248-54. 2006
  9. doi Does the impact of subsequent incontinence risk factors depend on continence status during the first pregnancy or the postpartum period 12 years before? A cohort study in 232 primiparous women
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Copenhagen, Denmark
    Am J Obstet Gynecol 199:73.e1-4. 2008
  10. pmc Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
    Mallik Angalakuditi
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, IN, USA
    Health Qual Life Outcomes 8:131. 2010

Detail Information

Publications25

  1. ncbi The risk of lower urinary tract symptoms five years after the first delivery
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Denmark
    Neurourol Urodyn 21:2-29. 2002
    ..To estimate the prevalence and 5-year incidence of lower urinary tract symptoms (LUTS) after the first delivery and to evaluate the impact of pregnancy per se and delivery per se on long-lasting symptoms. MATERIALS and..
  2. pmc Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Lars Viktrup
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    BMC Urol 12:30. 2012
    ..The aim of this study was to provide evidence of the validity of the 1-item Patient Global Impression of Severity (PGI-S) and Improvement (PGI-I) questionnaires for use as outcome measures in the treatment of BPH-LUTS...
  3. pmc Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial
    Alex Tong Long Lin
    Division of Urology, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
    BMC Urol 8:2. 2008
    ..This manuscript compares the efficacy and safety of duloxetine with placebo in Taiwanese women with SUI...
  4. ncbi [Urinary incontinence during 12 years after delivery]
    Lars Viktrup
    Københavns Universitet og Glostrup Hospital, Gynaekologisk og obstetrisk afdeling, Denmark
    Ugeskr Laeger 171:3073-7. 2009
    ..First pregnancy and delivery often result in urinary incontinence. The aim of this 12-year cohort study was to estimate the impact of incontinence and the need for treatment...
  5. doi Incidence and remission of lower urinary tract symptoms during 12 years after the first delivery: a cohort study
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Copenhagen, Denmark
    J Urol 180:992-7. 2008
    ..We estimated the incidence and remission of lower urinary tract symptoms during the 12 years following the first pregnancy and delivery...
  6. ncbi Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy
    Lars Viktrup
    Duloxetine Urinary Incontinence Study Group, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Eur J Obstet Gynecol Reprod Biol 133:105-13. 2007
    ..Duloxetine has been shown to be effective in women with stress urinary incontinence (SUI)...
  7. ncbi A retrospective pooled analysis of duloxetine safety in 23,983 subjects
    James Gahimer
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA
    Curr Med Res Opin 23:175-84. 2007
    ..The objective of this manuscript is to characterize the overall safety profile of duloxetine, regardless of indication, based on data from the duloxetine exposures integrated safety database...
  8. ncbi Risk of stress urinary incontinence twelve years after the first pregnancy and delivery
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Denmark
    Obstet Gynecol 108:248-54. 2006
    ..To estimate the impact of onset of stress urinary incontinence in first pregnancy or postpartum period, for the risk of symptoms 12 years after the first delivery...
  9. doi Does the impact of subsequent incontinence risk factors depend on continence status during the first pregnancy or the postpartum period 12 years before? A cohort study in 232 primiparous women
    Lars Viktrup
    Department of Obstetrics and Gynecology, Glostrup County Hospital, University of Copenhagen, Copenhagen, Denmark
    Am J Obstet Gynecol 199:73.e1-4. 2008
    ..Assess the impact of subsequent urinary incontinence risk factors in women with different urinary incontinence history...
  10. pmc Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
    Mallik Angalakuditi
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, IN, USA
    Health Qual Life Outcomes 8:131. 2010
    ..To assess the measurement properties of the Benign Prostatic Hyperplasia Impact Index (BII) for use in men with Lower Urinary Tract Symptoms (LUTS) secondary to Benign Prostatic Hyperplasia (BPH) treated with tadalafil...
  11. doi Urinary incontinence during pregnancy and 1 year after delivery in primiparous women compared with a control group of nulliparous women
    Bent Brandt Hansen
    Department of Obstetrics and Gynecology, University of Copenhagen, Copenhagen, Denmark
    Neurourol Urodyn 31:475-80. 2012
    ..To investigate the impact of the first pregnancy and delivery on the prevalence and types of urinary incontinence during pregnancy and 1 year after delivery...
  12. doi Reductions in stress urinary incontinence episodes: what is clinically important for women?
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, Indiana 46285, USA
    Neurourol Urodyn 29:344-7. 2010
    ..To expand our understanding of the clinical importance to patients with stress urinary incontinence (SUI) of reductions in incontinence episode frequency (IEF) that fall short of a complete cure...
  13. ncbi Safety and adverse event profile of duloxetine
    Joachim F Wernicke
    Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Expert Opin Drug Saf 4:987-93. 2005
    ..The purpose of this review is to provide an overview of some of the most important information related to safety and tolerability of duloxetine...
  14. pmc The handling of urinary incontinence in Danish general practices after distribution of guidelines and voiding diary reimbursement: an observational study
    Lars Viktrup
    The Research Unit for General Practice, Frederiksborg County, Denmark
    BMC Fam Pract 5:13. 2004
    ..The aim of this study was to identify the handling of urinary incontinence (UI) in Danish general practices after distribution of clinical guidelines and reimbursement for using a UI diary...
  15. ncbi Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety
    Daniel J Hurley
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Eur J Obstet Gynecol Reprod Biol 125:120-8. 2006
    ..The objective was to characterize the safety of duloxetine for treatment of stress urinary incontinence (SUI) in women, using an integrated database generated from four published placebo-controlled clinical trials...
  16. ncbi Comparison of physician and patient assessments of incontinence severity and improvement
    Ilker Yalcin
    Lilly Research Laboratories, Indianapolis, IN, USA
    Int Urogynecol J Pelvic Floor Dysfunct 18:1291-5. 2007
    ..46 and 0.44). In this study, the subjective (patient) and objective (clinician) assessments of SUI improvement with treatment appear to be more closely aligned than are the assessments of initial SUI severity...
  17. ncbi Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey
    Shonda A Foster
    Eli Lilly and Company, Indianapolis, IN, USA
    Curr Med Res Opin 29:1709-17. 2013
    ..There is limited epidemiology information on coexisting ED and BPH. This study assessed self-reported prevalence of ED with or without a diagnosis of BPH (ED/DxBPH versus ED only) in US men...
  18. ncbi The impact of stress urinary incontinence on sexual activity in women
    Matthew D Barber
    Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 72:225-32. 2005
    ....
  19. ncbi Pharmacological agents used for the treatment of stress urinary incontinence in women
    Lars Viktrup
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    Curr Med Res Opin 19:485-90. 2003
    ..A new centrally-acting compound with dual activity as a balanced serotonin and norepinephrine reuptake inhibitor, duloxetine, may offer a promising new approach for treatment...
  20. pmc Addressing the need for a simpler algorithm for the management of women with urinary incontinence
    Lars Viktrup
    Lilly Research Laboratories, Indianapolis, Indiana, USA
    MedGenMed 7:62. 2005
    ..I review the opportunity to develop a simpler UI algorithm based on the 3rd edition 2005 International Consultation of Incontinence (ICI) guidelines for the initial management of UI in women...
  21. ncbi Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused review
    Lars Viktrup
    Clinical Research Physician at Eli Lilly Research Laboratories, Eli Lilly and Company Faris II, Drop Code 6112, Indianapolis, IN 46285, USA
    Int J Gynaecol Obstet 86:S25-37. 2004
    ..The challenge of implementing guidelines in the US was also identified...
  22. ncbi Stress urinary incontinence in active elderly women
    Lars Viktrup
    Lilly Research Laboratories, Indianapolis, IN, USA
    South Med J 98:79-89. 2005
    ..We evaluate the age-related changes of the lower urinary tract, examine risk factors, and suggest different treatment options shown to be effective in reducing SUI in this population...
  23. ncbi The role of general practitioners in the initial management of women with urinary incontinence in France, Germany, Spain and the UK
    Máire O'Donnell
    Section for General Practice, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
    Eur J Gen Pract 13:20-6. 2007
    ..To describe the role of general practitioners (GPs) in the initial management of women with urinary incontinence (UI) in four European countries with different healthcare systems...
  24. ncbi Pharmacotherapy for stress urinary incontinence : present and future options
    Norman R Zinner
    Western Clinical Research Inc, 23441 Madison Street, Suite 130, Torrance, CA 90505, USA
    Drugs 64:1503-16. 2004
    ..A medication such as duloxetine, if approved, would go a long way towards expanding the available treatment options for patients with SUI...
  25. doi Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study
    Claus G Roehrborn
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    J Urol 180:1228-34. 2008
    ..Preliminary data have suggested phosphodiesterase type 5 inhibitor efficacy in men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia...